Transient bilateral cataract during intensive glucose control: a case report
© The Author(s). 2017
Received: 29 December 2016
Accepted: 19 March 2017
Published: 12 April 2017
Cataracts are generally known to occur in hyperglycemic conditions in diabetic patients. In this case, cataract occurred in the course of glucose level control in a patient who had been in a hyperglycemic state.
A 42-year-old Korean man who had uncontrolled diabetes for more than a year presented with bilateral posterior subcapsular cataracts, which developed within days of initiating antihyperglycemic therapy. With control of his serum glucose level for several weeks, the cataracts regressed.
Transient cataracts can develop during the hypoglycemic state; prompt surgery should be deferred.
KeywordsDiabetes Cataract Glucose control Hyperopic shift Osmotic stress Case report
Cataracts are one of the earliest complications of diabetes mellitus (DM). Patients with diabetes mellitus are two to five times more likely to develop cataracts compared to nondiabetic patients .
The pathogenesis of cataracts in the hyperglycemic environment is well established . There are some case reports regarding the development of transient diabetic cataracts while the patients were in a hyperglycemic state, which regressed after good glycemic control .
We describe a case of bilateral transient cataracts that developed while the patient’s blood glucose level was being rapidly lowered. Supportive photo-documentation was obtained.
A 42-year-old Korean man visited a cardiology clinic for management of hypertension. He had been prescribed antihypertensive and lipid-lowering agents for years and had been followed up irregularly. The medications include losartan 50 mg, fenofibrate 160 mg and a combination capsule of simvastatin 20 mg and ezetimibe 10 mg. On routine checkup, his blood test results were as follows: fasting plasma glucose (FPG), 555 mg/dL; serum creatinine, 2.29 mg/dL; serum sodium, 140 mmol/L; serum triglycerides, 792 mg/dL; glycosylated hemoglobin (HbA1c), 14.9%. Review of his medical history revealed that he had high FPG levels 1 year prior to the consult during a routine checkup. Treatment had been recommended, but he did not undergo further workup. Our patient was immediately started on oral hypoglycemic agents and was referred to the department of ophthalmology for evaluation of diabetic retinopathy.
On ophthalmic examination, his uncorrected visual acuity (UCVA) was 20/200 and best corrected visual acuity (BCVA) was 20/20 in both eyes. He had mild myopia, with -3.25 diopters (D) of spherical equivalent in both eyes, which was the same as his own glasses. The lenses were clear in both eyes and the remainder of the ophthalmic examination findings were normal.
Ten days after the first visit, he complained that he could not see well with his own glasses. His visual acuity with his own glasses was 20/40 in the right eye and 20/50 in the left eye. His BCVAs were 20/25 in both eyes. Manifest refraction showed mild hyperopia, with +1.0 D of spherical equivalent in both eyes. A slit-lamp examination revealed essentially clear lenses except for scattered fine opacities in the posterior subcapsular region.
Timeline of our patient’s clinical course
Past medical history
High blood glucose level 1 year before initial visit
Symptoms and medical findings
Fasting plasma glucose: 555 mg/dL
Best corrected visual acuity: 20/20 in both eyes
Refractive error: -3.25 diopters (D) in both eyes
Begins oral hypoglycemic agent
Diabetic retinopathy (-)
Feels blurred vision
Switches to insulin
Fasting plasma glucose: 214 mg/dL
Best corrected visual acuity: 20/40 in the right eye; 20/50 in the left eye
Bilateral subcapsular cataract
Retinal hemorrhage and exudates
Cannot see well with his own glasses
Visual acuity with his glasses: 20/40 in the right eye; 20/50 in the left eye
Best corrected visual acuity: 20/25 in both eyes
Refractive error: +1.0D in both eyes
Better visual acuity
Best corrected visual acuity: 20/25
Refractive error: -1.75D in both eyes
Previous reports suggest that transient cataracts develop in hyperglycemic conditions, especially in type I DM, as sorbitol accumulates in lens fibers and regresses as blood glucose level is regulated . However, this patient would have been hyperglycemic for a considerable period because he had been told that his blood glucose level was high 1 year prior to consult and his HbA1c result was 14.9%. As he had visited our clinic for routine screening evaluation before he was started on a hypoglycemic agent, his lenses were found to be clear on the first visit. Although we did not take a photograph of his lenses, his visual acuity was 20/20 in both eyes and he did not complain of blurred vision. Therefore, it can be postulated that the cataracts developed while the blood glucose level lowered sharply. The mechanism cannot be explained clearly, but it can be assumed that the homogeneity of the lens fiber is broken by the change in the membrane permeability because of the rapid osmotic pressure change .
At the same time, a hyperopic shift occurred temporarily. As the osmolality in aqueous humor was sharply lowered, the fluid would influx into the lens; the lens was swollen, which caused temporary hyperopia.
Our case illustrates a possible effect of glycemic control. Transient cataracts can occur while the blood glucose level is being lowered from a hyperglycemic condition. This type of cataract can be completely reversible and refractive change can accompany it. Recognition of the potential reversibility of this type of cataract can avoid unnecessary surgery.
Not applicable. There is no funding to be declared for this study.
Availability of data and materials
JHP drafted and revised the initial manuscript and completed a review of the literature. The author is accountable for all aspects of the work. The author read and approved the final manuscript.
The author declares that he has no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
The study was approved by the Institutional Review Board of the Seoul Paik Hospital of Inje University (IRB File No. 2016-12-010). Written informed consent was obtained from the patient involved in this study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol. 1995;119:295–300.View ArticlePubMedGoogle Scholar
- Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608–751.View ArticleGoogle Scholar
- Trindade F. Transient cataract and hypermetropization in diabetes mellitus: case report. Arq Bras Oftalmol. 2007;70:1037–9.View ArticlePubMedGoogle Scholar
- Phillip M, Ludwick DJ, Armour KM, et al. Transient subcapsular cataract formation in a child with diabetes. Clin Pediatr. 1993;32:684–5.View ArticleGoogle Scholar
- Jedziniak JA, Chylack Jr LT, Cheng HM, et al. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase. Invest Ophthalmol Vis Sci. 1981;20:314–26.PubMedGoogle Scholar